XB
Xbrane Bioppharma AB Stock: price and insider trades · Sweden
ISIN SE0012816510SE·
No insider purchase over the last 90 days. The latest, by Siavash Bashiri, was filed 16 Jul 2019.
Xbrane Bioppharma AB: what insiders have been doing
Xbrane Bioppharma AB has a thin disclosure history in our data (latest filing: 16 July 2019). New filings will appear here as soon as they are published. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Insider Decl.
1
Thresholds
n/a
Buy Volume
€5,852
1 ops. · all time
Sell Volume
n/a
n/a
Financial data
· cache
Last declaration on 16 July 2019
Declarations1 total
- 1,845 shares@ SEK 33.50100.0% of flowBTA (betald tecknad aktie)ISIN SE0012816510FI:csv-6253a1a505af66c69424Canonical exit: 10 Oct 2019 (T+90)
1 of 1 declaration
About Xbrane Bioppharma AB
Xbrane Biopharma AB is a biopharmaceutical company focused on the development of biosimilars. It is listed on the XSTO exchange.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations